ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261451.1	Motesanib	Breast invasive carcinoma	0.049602812	Resistant
ENSG00000261451.1	Motesanib	Liver hepatocellular carcinoma	0.011976961	Resistant